Ipamorelin FDA approval status explained: the peptide is not approved for human use, sits on the FDA's 503A Category 2 list, and has no legal US version.
Ipamorelin is not FDA-approved for any human use in the United States. The FDA has never approved it as a prescription drug, and in 2023 the agency added it to the 503A Category 2 list of bulk drug substances that compounding pharmacies may not use. There is no FDA-approved ipamorelin product on the US market today.
What Ipamorelin Is
Ipamorelin is a synthetic pentapeptide that acts as a growth hormone secretagogue. It binds the ghrelin receptor in the pituitary gland and triggers growth hormone release.
The peptide was developed in the 1990s by Novo Nordisk researchers looking for a more selective secretagogue. Early animal work and a few small human studies suggested it raises growth hormone with less effect on cortisol and prolactin than older compounds.
Those studies enrolled few participants and ran for short periods, so they were never designed to meet FDA approval standards. Ipamorelin is not a steroid; it is a peptide, typically sold as a lyophilized powder that users mix and inject.
Ipamorelin FDA Approval Status at a Glance
The short answer to the ipamorelin FDA approval question is no, and the table below shows how its status compares with related compounds.
| Compound | FDA-approved for human use? | Notes |
|---|---|---|
| Ipamorelin | No | On the 503A Category 2 list since 2023; no approved indication |
| CJC-1295 | No | Also on the 503A Category 2 list |
| Tesamorelin (Egrifta SV) | Yes | Approved for excess abdominal fat in adults with HIV |
| Macimorelin (Macrilen) | Yes | Approved to diagnose adult growth hormone deficiency |
| Sermorelin (Geref) | No longer marketed | Once FDA-approved, later discontinued |
| Somatropin | Yes | Approved for specific growth hormone deficiency diagnoses |
Ipamorelin has no approved indication for weight loss, muscle growth, anti-aging, or any other purpose.
Why the FDA Has Not Approved Ipamorelin
The FDA approves a drug only when controlled trials show it is safe and effective for a specific medical condition. Ipamorelin has never been through that process.
- No large randomized, placebo-controlled human trials have been completed.
- There is no defined disease or condition that ipamorelin is proven to treat.
- Long-term effects on the pituitary, blood sugar, and hormone feedback loops are unknown.
- Injectable peptides must meet strict sterility and manufacturing standards that most gray-market suppliers cannot document.
The Category 2 designation reflects the agency's view that these substances raise safety concerns and lack sufficient evidence to support compounding. The FDA has kept ipamorelin and similar peptides on that list while it continues to evaluate them.
Is Ipamorelin Legal in the US?
Legality depends on how the peptide is sold, not on who buys it. A "research use only" label does not make it legal to sell ipamorelin for human consumption.
| How it is sold | Typical seller | Legal status |
|---|---|---|
| "Research chemical" | Online peptide vendors | Legal for laboratory research only; not legal to sell for human use |
| Compounded prescription | 503A compounding pharmacies | Not permitted, because ipamorelin is on the Category 2 list |
| Prescription drug | Retail or mail-order pharmacies | Does not exist; there is no FDA-approved ipamorelin product |
The FDA has sent warning letters to companies that market unapproved peptides for human use. Buying from an online vendor also means no guarantee of purity, correct dosage, or sterility.
CJC-1295, Ipamorelin, and Other Peptides Waiting on the FDA
Ipamorelin is often stacked with CJC-1295, another growth hormone-related peptide. Search interest in cjc-1295 ipamorelin fda-approved status keeps climbing, but neither compound has cleared the FDA, and both appear on the same 503A Category 2 list.
Many people who ask is cjc-1295/ipamorelin fda-approved are really asking whether a doctor can prescribe the blend. A licensed prescriber cannot legally order compounded ipamorelin, because no 503A pharmacy may use it as a bulk ingredient.
Other peptides are further along in the pipeline. The elamipretide fda approval application reached an FDA advisory committee even though the drug has not been approved. SS-31 is another name for elamipretide, so ss 31 fda approval news describes the very same application.
Retatrutide is a different case entirely: retatrutide fda approval is still years away at best, because the drug remains in Phase 3 clinical trials.
FDA-Approved Alternatives and Safety Considerations
Patients who need growth hormone evaluation or treatment have legal, FDA-approved options.
- Diagnostic testing: macimorelin (Macrilen) is approved to diagnose adult growth hormone deficiency.
- Replacement therapy: somatropin products are approved for specific growth hormone deficiency diagnoses in children and adults.
- Tesamorelin (Egrifta SV): approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy.
Side effects reported in small ipamorelin studies include injection site reactions, headache, and short-lived changes in hunger or blood sugar. Because it drives growth hormone release, ipamorelin may be inappropriate for people with active cancer, pituitary disease, or uncontrolled diabetes.
Anyone considering ipamorelin should talk with a licensed healthcare professional first. Self-treating with an unapproved peptide means accepting unknown risks with no regulatory safety net, and no way to verify what is actually in the vial.
There is no FDA-approved version of ipamorelin, CJC-1295, or any compounded ipamorelin blend.
Frequently Asked Questions
Is ipamorelin FDA-approved for human use?
No. Ipamorelin has never received FDA approval for any human indication, and the agency placed it on the 503A Category 2 list of bulk drug substances that compounding pharmacies may not use. There is no FDA-approved ipamorelin product available by prescription in the United States.
Is it legal to buy ipamorelin in the US?
Ipamorelin is sold legally as a research chemical for laboratory use, but it is not legal to sell it as a dietary supplement or a prescription drug for human use. Because these gray-market products are not FDA-regulated, purity, sterility, and actual dosing are not guaranteed.
Are there FDA-approved alternatives to ipamorelin?
Yes. Tesamorelin (Egrifta SV) is approved for excess abdominal fat in adults with HIV, macimorelin (Macrilen) is approved to diagnose adult growth hormone deficiency, and somatropin is approved for specific growth hormone deficiency diagnoses. A licensed physician can order appropriate testing and discuss whether any of these treatments fit your situation.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.